Planned Parenthood: Trump Administration Asks SCOTUS to Reinstate Medically Unnecessary Barriers to Medication Abortion During Pandemic
August 27, 2020
August 27, 2020
NEW YORK, Aug. 27 -- The Planned Parenthood Federation of America issued the following news release on Aug. 26:
Today, the Trump Administration asked the Supreme Court to reinstate a U.S. Food and Drug Administration (FDA) policy that unnecessarily subjects patients to COVID-19 risks in order to access safe and legal medication abortion during the pandemic. The FDA's Risk Evaluation and Mitigation Strategy (REMS) restrictions on mifepristone mandate that patients pick up mifepriston . . .
Today, the Trump Administration asked the Supreme Court to reinstate a U.S. Food and Drug Administration (FDA) policy that unnecessarily subjects patients to COVID-19 risks in order to access safe and legal medication abortion during the pandemic. The FDA's Risk Evaluation and Mitigation Strategy (REMS) restrictions on mifepristone mandate that patients pick up mifepriston . . .